The FcγRIIa polymorphism in patients with chronic kidney graft rejection

Transplantation Proceedings

Volumn 36, Issue 5, 2004, Pages 1311-1313

  Pawlik, A ^a   Florczak, M ^b   Bak, L ^b   Dabrowska Zamojcin E ^b   Rozanski, J ^b   Domanski, L ^b   Gawronska Szklarz, B ^b  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; FC RECEPTOR; GENOMIC DNA; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; FC GAMMA RECEPTOR IIA; LEUKOCYTE ANTIGEN; PRIMER DNA;

ADULT; AGED; ALLOGRAFT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; FEMALE; GENETIC RISK; GENOTYPE; HUMAN; HUMAN TISSUE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECIPIENT; ALLOTRANSPLANTATION; FOLLOW UP; GENETIC POLYMORPHISM; GENETICS; GRAFT REJECTION; IMMUNOLOGY; MIDDLE AGED; NUCLEOTIDE SEQUENCE; RETROSPECTIVE STUDY; RISK FACTOR; TIME;

ADULT; ANTIGENS, CD; BASE SEQUENCE; DNA PRIMERS; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, IGG; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 3142574669     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.05.076     Document Type: Article

References (23)

1. Salmon J.E., Edberg J.C., Brogle N.L., et al. Allelic polymorphisms of human Fcγ receptor IIA and Fcγ receptor IIIB. Independent mechanisms for differences in human phagocyte function. J Clin Invest. 89:1992;1274
2. Parren P.W.H.I., Warmerdam P.A.M., Boeije L.C.M. On the interaction of IgG subclasses with the low affinity Fcγ R IIa (CD32) on human monocytes, neutrophils, and platelets: analysis of a functional polymorphism to human IgG2. J Clin Invest. 90:1992;1537
3. Rosenfeld S.I., Looney R.J., Leddy J.P., et al. Human platelet Fc receptor for immunoglobulin. G. J Clin Invest. 76:1985;2317
4. Warmerdam P.A.M., Van de Winkel J.G.J., Gosselin E.J., et al. Molecular basis for a polymorphism of human Fcγ receptor II (CD32). J Exp Med. 172:1990;19
5. Sanders L.A.M., Van de Winkel J.G.J., Rijkers G.T. Fcγ receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J Infect Dis. 170:1994;854
6. Carlsson L.E., Santoso S., Baurichter G., et al. Heparin-induced thrombocytopenia new insights into the impact of the FcγR IIa-R-H131 polymorphism. Blood. 92:1998;1526
7. Duits A.J., Bootsma H., Derksen R.H.W.M. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum. 39:1995;1832
8. Tax W.J., Holtrop S., Koene R.A. Clinical implications of the polymorphic interaction of murine IgG2b and IgG1 with human Fc receptors. Transpl Immunol. 1:1993;250
9. gamma RII) is reflected in cytokine release and adverse effects of mIgG1 anti-CD3/TCR antibody during rejection treatment after renal transplantation. Transplant Proc. 27:1995;867
10. gammaRIIa in cytokine release and adverse effects of murine IgG1 anti-CD3/T cell receptor antibody (WT31). Transplantation. 63:1997;106
11. gammaRIIA polymorphism and renal allograft survival. Transplant Proc. 34:2002;3138
12. Kasiske B.L., Kalil R.S., Lee H.S., et al. Histopathologic findings associated with a chronic, progressive decline in renal allograft function. Kidney Int. 40:1991;514
13. Solez K. International standardization of criteria for histologic diagnosis of chronic rejection in renal allografts. Clin Transplant. 8:1994;345
14. Solez K. Graft atherosclerosis and chronic rejection in the kidney. Transplant Proc. 29:1997;2541
15. Racusen L.C., Solez K., Colvin R.B., et al. The Banff-97 working classification of renal allograft pathology. Kidney Int. 55:1999;713
16. Flesch B.K., Bauer F., Neppert J. Rapid typing the human Fcγreceptor IIA polymorphism by polymerase chain reaction amplification with allele-specific primers. Transfusion. 38:1998;174
17. Häyry P., Aavik E., Savolainen H. Mechanisms of chronic rejection. Transplant Proc. 31:(Suppl 7A):1999;5S
18. Delafontaine P., Brink M., Anwar A., et al. Growth factors and receptors in allograft arteriosclerosis. Transplant Proc. 31:1999;111
19. Matas A.J. Risk factors for chronic rejection - a clinical perspective. Transpl Immunol. 6:1998;1
20. Simonson M.S., Herman W.H., Knauss T.C., et al. Macrophages - but not T-cell-derived cytokines - stimulate endothelin-1 secretion by endothelial cells. Transplant Proc. 31:1999;806
21. gamma-receptor blocking factors associated with renal allograft survival. Transplant Proc. 19:1987;4268
22. gamma-receptor blocking activity. Transplant Proc. 21:1989;876
23. gamma-receptor blocking factors in human renal transplantation. Immunol Lett. 26:1990;153